{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:48:55Z","timestamp":1789778935824,"version":"4.0.1"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2012,1,27]],"date-time":"2012-01-27T00:00:00Z","timestamp":1327622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Cytokines play a major role in bone remodeling in vitro and in animal models, with evidence supporting the involvement of inflammatory markers in the pathogenesis of osteoporosis. However, less is known about the longitudinal association of inflammatory markers with hip fracture. We tested whether high receptor levels of proinflammatory cytokines are associated with an increased risk of hip fracture in older women. We used a nested case-control study design from the Women's Health Initiative Observational Study (WHI-OS) and selected 400 cases with physician-adjudicated incident hip fractures and 400 controls matched on age, race, and date of blood draw. Participants were chosen from 39,795 postmenopausal women without previous hip fractures, not using estrogens or other bone-active therapies. Incident hip fractures (median follow-up 7.1 years) were verified by review of radiographs and confirmed by blinded central adjudicators. Hip fractures with a pathological cause were excluded. In multivariable models, the risk of hip fracture for subjects with the highest levels of inflammatory markers (quartile 4) compared with those with lower levels (quartiles 1, 2, and 3) was 1.43 (95% confidence interval [CI], 0.98\u20132.07) for interleukin-6 (IL-6) soluble receptor (SR), 1.40 (95% CI, 0.97\u20132.03) for tumor necrosis factor (TNF) SR1, and 1.56 (95% CI, 1.09\u20132.22) for TNF SR2. In subjects with all three markers in the highest quartile, the risk ratio of fracture was 2.76 (95% CI, 1.22\u20136.25) in comparison with subjects with 0 or 1 elevated marker(s) (p trend\u2009=\u20090.018). Elevated levels of inflammatory markers for all three cytokine-soluble receptors were associated with an increased risk of hip fractures in older women. Future clinical trials should test whether interventions to decrease inflammatory marker levels reduces hip fractures. \u00a9 2012 American Society for Bone and Mineral Research.<\/jats:p>","DOI":"10.1002\/jbmr.1559","type":"journal-article","created":{"date-parts":[[2012,1,27]],"date-time":"2012-01-27T23:46:43Z","timestamp":1327708003000},"page":"1167-1176","source":"Crossref","is-referenced-by-count":134,"title":["Inflammatory markers and the risk of hip fracture: The women's health initiative"],"prefix":"10.1093","volume":"27","author":[{"given":"Kamil E","family":"Barbour","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Boudreau","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle E","family":"Danielson","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada O","family":"Youk","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Wactawski-Wende","sequence":"additional","affiliation":[{"name":"Department of Social and Preventive Medicine, University at Buffalo, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy C","family":"Greep","sequence":"additional","affiliation":[{"name":"Department of Endocrine\/Bone Disease, John Wayne Cancer Institute, Santa Monica, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Z","family":"LaCroix","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca D","family":"Jackson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ohio State University, Ohio, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B","family":"Wallace","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Iowa, Iowa City, IA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas C","family":"Bauer","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A","family":"Allison","sequence":"additional","affiliation":[{"name":"Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A","family":"Cauley","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,1,27]]},"reference":[{"issue":"3","key":"2024020318260558400_bib1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2337\/diabetes.53.3.693","article-title":"Inflammatory markers and risk of developing type 2 diabetes in women","volume":"53","author":"Hu","year":"2004","journal-title":"Diabetes."},{"issue":"5","key":"2024020318260558400_bib2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(99)00066-2","article-title":"Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly","volume":"106","author":"Harris","year":"1999","journal-title":"Am J Med."},{"issue":"6","key":"2024020318260558400_bib3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1532-5415.1999.tb01583.x","article-title":"Serum IL-6 level and the development of disability in older persons","volume":"47","author":"Ferrucci","year":"1999","journal-title":"J Am Geriatr Soc."},{"issue":"3","key":"2024020318260558400_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.59.3.371","article-title":"Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging","volume":"59","author":"Weaver","year":"2002","journal-title":"Neurology."},{"issue":"6","key":"2024020318260558400_bib5","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0197-4580(01)00289-5","article-title":"Inflammation, autotoxicity and Alzheimer disease","volume":"22","author":"McGeer","year":"2001","journal-title":"Neurobiol Aging."},{"issue":"2","key":"2024020318260558400_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cardiores.2004.12.026","article-title":"Inflammatory markers and cardiovascular health in older adults","volume":"66","author":"Kritchevsky","year":"2005","journal-title":"Cardiovasc Res."},{"issue":"25","key":"2024020318260558400_bib7","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa040967","article-title":"Inflammatory markers and the risk of coronary heart disease in men and women","volume":"351","author":"Pai","year":"2004","journal-title":"N Engl J Med."},{"issue":"7","key":"2024020318260558400_bib8","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1210\/endo.136.7.7789332","article-title":"Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period","volume":"136","author":"Kimble","year":"1995","journal-title":"Endocrinology."},{"issue":"2","key":"2024020318260558400_bib9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1359\/jbmr.2001.16.2.328","article-title":"T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms","volume":"16","author":"Weitzmann","year":"2001","journal-title":"J Bone Miner Res."},{"issue":"8","key":"2024020318260558400_bib10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2174\/1381612013397807","article-title":"Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption","volume":"7","author":"Kostenuik","year":"2001","journal-title":"Curr Pharm Des."},{"issue":"18","key":"2024020318260558400_bib11","doi-asserted-by":"crossref","first-page":"10405","DOI":"10.1073\/pnas.1533207100","article-title":"Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator","volume":"100","author":"Cenci","year":"2003","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5066","key":"2024020318260558400_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1621100","article-title":"Increased osteoclast development after estrogen loss: mediation by interleukin-6","volume":"257","author":"Jilka","year":"1992","journal-title":"Science."},{"issue":"7","key":"2024020318260558400_bib13","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1359\/jbmr.070409","article-title":"Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study","volume":"22","author":"Cauley","year":"2007","journal-title":"J Bone Miner Res."},{"issue":"4","key":"2024020318260558400_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1210\/er.2008-0002","article-title":"Osteoporosis in men","volume":"29","author":"Khosla","year":"2008","journal-title":"Endocr Rev."},{"issue":"19","key":"2024020318260558400_bib15","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.162.19.2217","article-title":"Undertreatment of osteoporosis in men with hip fracture","volume":"162","author":"Kiebzak","year":"2002","journal-title":"Arch Intern Med."},{"issue":"12","key":"2024020318260558400_bib16","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/jbmr.5650111215","article-title":"A prospective study on socioeconomic aspects of fracture of the proximal femur","volume":"11","author":"Schurch","year":"1996","journal-title":"J Bone Miner Res."},{"issue":"3","key":"2024020318260558400_bib17","first-page":"157","article-title":"Variation in serum levels of the soluble TNF receptors among healthy individuals","volume":"11","author":"Aderka","year":"1992","journal-title":"Lymphokine Cytokine Res."},{"issue":"7","key":"2024020318260558400_bib18","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.4049\/jimmunol.148.7.2175","article-title":"Human soluble IL-6 receptor: its detection and enhanced release by HIV infection","volume":"148","author":"Honda","year":"1992","journal-title":"J Immunol."},{"issue":"11","key":"2024020318260558400_bib19","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1073\/pnas.89.11.4845","article-title":"Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo","volume":"89","author":"Van Zee","year":"1992","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"9 Suppl","key":"2024020318260558400_bib20","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1047-2797(03)00042-5","article-title":"The Women's Health Initiative recruitment methods and results","volume":"13","author":"Hays","year":"2003","journal-title":"Ann Epidemiol."},{"issue":"9 Suppl","key":"2024020318260558400_bib21","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S1047-2797(03)00048-6","article-title":"Outcomes ascertainment and adjudication methods in the Women's Health Initiative","volume":"13","author":"Curb","year":"2003","journal-title":"Ann Epidemiol."},{"issue":"3","key":"2024020318260558400_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1047-2797(98)00055-6","article-title":"Measurement characteristics of the Women's Health Initiative food frequency questionnaire","volume":"9","author":"Patterson","year":"1999","journal-title":"Ann Epidemiol."},{"issue":"10","key":"2024020318260558400_bib23","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMoa021067","article-title":"Walking compared with vigorous exercise for the prevention of cardiovascular events in women","volume":"347","author":"Manson","year":"2002","journal-title":"N Engl J Med."},{"issue":"3","key":"2024020318260558400_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hec.4730020305","article-title":"The RAND 36-Item Health Survey 1.0","volume":"2","author":"Hays","year":"1993","journal-title":"Health Econ."},{"issue":"8","key":"2024020318260558400_bib25","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1532-5415.2005.53405.x","article-title":"Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study","volume":"53","author":"Woods","year":"2005","journal-title":"J Am Geriatr Soc."},{"issue":"9 Suppl","key":"2024020318260558400_bib26","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S1047-2797(03)00043-7","article-title":"Implementation of the Women's Health Initiative study design","volume":"13","author":"Anderson","year":"2003","journal-title":"Ann Epidemiol."},{"issue":"2","key":"2024020318260558400_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0002-9378(74)90040-4","article-title":"Clinical experience with the amniotic fluid lecithin-sphingomyelin ratio. II. The L-S ratio in \u201cstressed pregnancies","volume":"119","author":"Freeman","year":"1974","journal-title":"Am J Obstet Gynecol."},{"issue":"4","key":"2024020318260558400_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9378(74)90199-9","article-title":"Serum testosterone concentrations in women throughout the menstrual cycle and following HCG administration","volume":"119","author":"Goebelsmann","year":"1974","journal-title":"Am J Obstet Gynecol."},{"issue":"2","key":"2024020318260558400_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1677\/erc.0.0060165","article-title":"Aromatase and breast cancer susceptibility","volume":"6","author":"Probst-Hensch","year":"1999","journal-title":"Endocr Relat Cancer."},{"issue":"6","key":"2024020318260558400_bib30","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/0002-9378(88)90591-1","article-title":"A randomized comparison of nonoral estradiol delivery in postmenopausal women","volume":"159","author":"Stanczyk","year":"1988","journal-title":"Am J Obstet Gynecol."},{"issue":"10 Pt 1","key":"2024020318260558400_bib31","first-page":"1065","article-title":"Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations","volume":"11","author":"Rinaldi","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"6","key":"2024020318260558400_bib32","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0022-4731(82)90038-3","article-title":"Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature","volume":"16","author":"Sodergard","year":"1982","journal-title":"J Steroid Biochem."},{"issue":"10","key":"2024020318260558400_bib33","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2024020318260558400_bib34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7326\/0003-4819-149-4-200808190-00005","article-title":"Serum 25-hydroxyvitamin D concentrations and risk for hip fractures","volume":"149","author":"Cauley","year":"2008","journal-title":"Ann Intern Med."},{"issue":"7","key":"2024020318260558400_bib35","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1532-5415.2004.52308.x","article-title":"Inflammatory markers and incident mobility limitation in the elderly","volume":"52","author":"Penninx","year":"2004","journal-title":"J Am Geriatr Soc."},{"issue":"10","key":"2024020318260558400_bib36","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archpsyc.56.10.889","article-title":"Minor and major depression and the risk of death in older persons","volume":"56","author":"Penninx","year":"1999","journal-title":"Arch Gen Psychiatry."},{"issue":"8837","key":"2024020318260558400_bib37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0140-6736(93)92555-8","article-title":"Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group","volume":"341","author":"Cummings","year":"1993","journal-title":"Lancet."},{"issue":"1\u20132","key":"2024020318260558400_bib38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cellimm.2007.06.008","article-title":"Estrogen deficiency, T cells and bone loss","volume":"252","author":"Pacifici","year":"2008","journal-title":"Cell Immunol."},{"issue":"4","key":"2024020318260558400_bib39","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1210\/jc.2010-1902","article-title":"SHBG, sex hormones, and inflammatory markers in older women","volume":"96","author":"Maggio","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2024020318260558400_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2796.2008.01946.x","article-title":"Endogenous sex hormones and C-reactive protein in healthy postmenopausal women","volume":"264","author":"Stork","year":"2008","journal-title":"J Intern Med."},{"issue":"6","key":"2024020318260558400_bib41","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.annepidem.2004.10.004","article-title":"A positive or a negative confounding variable? A simple teaching aid for clinicians and students","volume":"15","author":"Mehio-Sibai","year":"2005","journal-title":"Ann Epidemiol."},{"issue":"1","key":"2024020318260558400_bib42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00398.x","article-title":"Biomarkers of inflammation and progression of chronic kidney disease","volume":"68","author":"Tonelli","year":"2005","journal-title":"Kidney Int."},{"issue":"4","key":"2024020318260558400_bib43","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1053\/j.ajkd.2008.10.044","article-title":"Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study","volume":"53","author":"Bash","year":"2009","journal-title":"Am J Kidney Dis."},{"issue":"12","key":"2024020318260558400_bib44","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1097\/01.ASN.0000146422.45434.35","article-title":"Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals","volume":"15","author":"Fried","year":"2004","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"2024020318260558400_bib45","first-page":"419","article-title":"Tumor necrosis factor induces glomerular damage in the rabbit","volume":"134","author":"Bertani","year":"1989","journal-title":"Am J Pathol."},{"issue":"12","key":"2024020318260558400_bib46","first-page":"1625","article-title":"Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice","volume":"78","author":"Le Hir","year":"1998","journal-title":"Lab Invest."},{"issue":"3","key":"2024020318260558400_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.ki.5002042","article-title":"Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study","volume":"71","author":"Keller","year":"2007","journal-title":"Kidney Int."},{"issue":"2","key":"2024020318260558400_bib48","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archinte.167.2.133","article-title":"Renal function and risk of hip and vertebral fractures in older women","volume":"167","author":"Ensrud","year":"2007","journal-title":"Arch Intern Med."},{"issue":"8","key":"2024020318260558400_bib49","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1532-5415.2008.01807.x","article-title":"Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women","volume":"56","author":"LaCroix","year":"2008","journal-title":"J Am Geriatr Soc."},{"issue":"1","key":"2024020318260558400_bib50","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1681\/ASN.2006050546","article-title":"Association of kidney function with incident hip fracture in older adults","volume":"18","author":"Fried","year":"2007","journal-title":"J Am Soc Nephrol."},{"key":"2024020318260558400_bib51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0105-2896.2005.00334.x","article-title":"The role of the immune system in the pathophysiology of osteoporosis","volume":"208","author":"Clowes","year":"2005","journal-title":"Immunol Rev."},{"issue":"8","key":"2024020318260558400_bib52","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1359\/jbmr.2000.15.8.1545","article-title":"Cytokines and bone loss in a 5-year longitudinal study\u2013hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study","volume":"15","author":"Abrahamsen","year":"2000","journal-title":"J Bone Miner Res."},{"issue":"5","key":"2024020318260558400_bib53","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/jc.2007-2325","article-title":"Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study","volume":"93","author":"Ding","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2024020318260558400_bib54","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jocd.2010.04.003","article-title":"Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation","volume":"13","author":"Gertz","year":"2010","journal-title":"J Clin Densitom."},{"issue":"5","key":"2024020318260558400_bib55","first-page":"2032","article-title":"Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause","volume":"86","author":"Scheidt-Nave","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"6053","key":"2024020318260558400_bib56","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/319516a0","article-title":"Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors","volume":"319","author":"Bertolini","year":"1986","journal-title":"Nature."},{"issue":"3","key":"2024020318260558400_bib57","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1210\/endo-124-3-1424","article-title":"Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice","volume":"124","author":"Johnson","year":"1989","journal-title":"Endocrinology."},{"issue":"2","key":"2024020318260558400_bib58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S8756-3282(98)00077-5","article-title":"Cytokines, bone remodeling, and estrogen deficiency: a 1998 update","volume":"23","author":"Jilka","year":"1998","journal-title":"Bone."},{"issue":"24","key":"2024020318260558400_bib59","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1073\/pnas.90.24.11924","article-title":"Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6","volume":"90","author":"Tamura","year":"1993","journal-title":"Proc Natl Acad Sci U S A."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.1559","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/27\/5\/1167\/56562166\/1559_ftp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/27\/5\/1167\/56562166\/1559_ftp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:46:07Z","timestamp":1710341167000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/27\/5\/1167-1176\/7598507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,27]]},"references-count":59,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,1,27]]},"published-print":{"date-parts":[[2012,5,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.1559","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,5,1]]},"published":{"date-parts":[[2012,1,27]]}}}